Case Type: Mergers & Acquisitions

ENDRA Life Sciences Inc. (NASDAQ: NDRA) related to its merger with Noble Africa LLC. Upon closing of the proposed transaction, ENDRA shareholders are expected to own approximately 3% of the combined company.

Bio-Techne Corporation (NASDAQ: TECH) related to its sale to Merck KGaA. Under the terms of the proposed transaction, Bio-Techne shareholders are expected to receive $73.00 per share in cash.

Synaptics Incorporated (NASDAQ: SYNA) related to its sale to onsemi. Under the terms of the proposed transaction, Synaptics shareholders will receive 1.350 shares of onsemi’s common stock for each Synaptics share.

First Reliance Bancshares, Inc. (OTCQX: FSRL) related to its sale to Colony Bankshares, Inc. Under the terms of the proposed transaction, First Reliance shareholders will receive either (i) $19.75 in cash or 0.94 of a share of Colony’s common stock in exchange for each share of First Reliance common stock.

Colony Bankcorp, Inc. (NYSE: CBAN) related to its merger with First Reliance Bancshares, Inc. Under the terms of the proposed transaction, First Reliance shareholders will receive either (i) $19.75 in cash or 0.94 of a share of Colony’s common stock in exchange for each share of First Reliance common stock.

Selectis Health, Inc. (OTCMKTS: GBCS) related to its sale to Black Pearl Equities II, LLC. Under the terms of the proposed transaction, Selectis Health shareholders will receive $5.75 per share in cash.

Boundless Bio, Inc. (NASDAQ: BOLD) related to its merger with Serapha Bio, Inc. Upon closing of the proposed transaction, Boundless Bio shareholders are expected to own approximately 3.7% of the combined company.

Apogee Therapeutics, Inc. (NASDAQ: APGE) related to its sale to AbbVie Inc. Under the terms of the proposed transaction, Apogee shareholders are expected to receive $135.11 per share in cash.

Arcosa, Inc. (NYSE: ACA) related to its sale to CRH Americas, Inc. Under the terms of the proposed transaction, Arcosa shareholders are expected to receive $150.00 per share in cash.

Simulations Plus, Inc. (NASDAQ: SLP) related to its sale to affiliates of Altaris, LLC. Under the terms of the proposed transaction, Simulations Plus shareholders are expected to receive $18.50 per share in cash.